Probiotic-based self-crosslinking bio-coating for the treatment of colitis by increasing probiotic colonization

from 0.73 % to 9.3 %. These results highlight the potential for BL@Map@Alg to enhance probiotic therapy by improving survival, colonization, and gut microbiota, offering a promising strategy for personalized and precision medicine.